In Vivo Sublayer Analysis of Human Retinal Inner Plexiform Layer Obtained by Visible-Light Optical Coherence Tomography.


Journal

Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701

Informations de publication

Date de publication:
03 01 2022
Historique:
entrez: 13 1 2022
pubmed: 14 1 2022
medline: 19 2 2022
Statut: ppublish

Résumé

Growing evidence suggests that dendrite retraction or degeneration in a subpopulation of the retinal ganglion cells (RGCs) may precede detectable soma abnormalities and RGC death in glaucoma. Visualization of the lamellar structure of the inner plexiform layer (IPL) could advance clinical management and fundamental understanding of glaucoma. We investigated whether visible-light optical coherence tomography (vis-OCT) could detect the difference in the IPL sublayer thicknesses between small cohorts of healthy and glaucomatous subjects. We imaged nine healthy and five glaucomatous subjects with vis-OCT. Four of the healthy subjects were scanned three times each in two separate visits, and five healthy and five glaucoma subjects were scanned three times during a single visit. IPL sublayers were manually segmented using averaged A-line profiles. The mean ages of glaucoma and healthy subjects are 59.6 ± 13.4 and 45.4 ± 14.4 years (P = 0.02.) The visual field mean deviations (MDs) are -26.4 to -7.7 dB in glaucoma patients and -1.6 to 1.1 dB in healthy subjects (P = 0.002). Median coefficients of variation (CVs) of intrasession repeatability for the entire IPL and three sublayers are 3.1%, 5.6%, 6.9%, and 5.6% in healthy subjects and 1.8%, 6.0%, 7.7%, and 6.2% in glaucoma patients, respectively. The mean IPL thicknesses are 36.2 ± 1.5 µm in glaucomatous and 40.1 ± 1.7 µm in healthy eyes (P = 0.003). IPL sublayer analysis revealed that the middle sublayer could be responsible for the majority of IPL thinning in glaucoma. Vis-OCT quantified IPL sublayers with good repeatability in both glaucoma and healthy subjects.

Identifiants

pubmed: 35024761
pii: 2778263
doi: 10.1167/iovs.63.1.18
pmc: PMC8762683
doi:

Types de publication

Comparative Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

18

Subventions

Organisme : NEI NIH HHS
ID : R01 EY026078
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY029121
Pays : United States
Organisme : NEI NIH HHS
ID : U01 EY033001
Pays : United States
Organisme : NEI NIH HHS
ID : T32 EY025202
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY013178
Pays : United States
Organisme : NEI NIH HHS
ID : R44 EY026466
Pays : United States

Références

Nat Rev Neurosci. 2004 Oct;5(10):747-57
pubmed: 15378035
J Opt Soc Am. 1980 Feb;70(2):220-3
pubmed: 7365564
Science. 1976 Oct 8;194(4261):193-5
pubmed: 959847
Exp Eye Res. 2017 May;158:43-50
pubmed: 27319294
Neurophotonics. 2019 Oct;6(4):041107
pubmed: 31482105
Br J Ophthalmol. 2006 Feb;90(2):186-90
pubmed: 16424531
Invest Ophthalmol Vis Sci. 2016 Sep 1;57(11):4799-4805
pubmed: 27654408
Ophthalmology. 2009 Dec;116(12):2305-14.e1-2
pubmed: 19744726
Biomed Opt Express. 2019 May 21;10(6):2918-2931
pubmed: 31259062
Br J Ophthalmol. 2006 Mar;90(3):262-7
pubmed: 16488940
Neuron. 2015 Mar 18;85(6):1244-56
pubmed: 25754821
Biomed Opt Express. 2018 Mar 05;9(4):1477-1491
pubmed: 29675296
BMC Bioinformatics. 2016 Jan 16;17:36
pubmed: 26772546
Annu Rev Neurosci. 2015 Jul 8;38:221-46
pubmed: 25897874
J Neurosci. 2015 Feb 11;35(6):2329-43
pubmed: 25673829
Ophthalmology. 2017 Dec;124(12S):S76-S82
pubmed: 29157365
eNeuro. 2017 Jan 17;4(1):
pubmed: 28101532
Opt Express. 2012 Jan 16;20(2):1337-59
pubmed: 22274479
J Neurophysiol. 1978 Mar;41(2):472-83
pubmed: 650277
J Opt Soc Am A Opt Image Sci Vis. 2007 May;24(5):1250-65
pubmed: 17429471
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT429-37
pubmed: 27409502
Brain Res. 1984 Apr 23;298(1):187-90
pubmed: 6722555
JAMA. 2014 May 14;311(18):1901-11
pubmed: 24825645
Prog Retin Eye Res. 2021 Jan;80:100875
pubmed: 32659431
Am J Ophthalmol. 2013 Dec;156(6):1297-1307.e2
pubmed: 24075422
Br J Ophthalmol. 2010 Mar;94(3):372-6
pubmed: 19770161
Prog Retin Eye Res. 2001 Mar;20(2):139-74
pubmed: 11173250
Am J Ophthalmol. 2004 Jan;137(1):156-69
pubmed: 14700659
PLoS One. 2013 Aug 19;8(8):e72282
pubmed: 23977271
Biomed Opt Express. 2013 Jan 1;4(1):51-65
pubmed: 23304647
Vision Res. 2013 Jan 14;76:31-42
pubmed: 23099046

Auteurs

Zeinab Ghassabi (Z)

Department of Ophthalmology, NYU Langone Health, NYU Grossman School of Medicine, New York, New York, United States.

Roman V Kuranov (RV)

Department of Biomedical Engineering, Northwestern University, Evanston, Illinois, United States.
Opticent Inc., Evanston, Illinois, United States.

Joel S Schuman (JS)

Department of Ophthalmology, NYU Langone Health, NYU Grossman School of Medicine, New York, New York, United States.
Department of Biomedical Engineering, New York University Tandon School of Engineering, Brooklyn, New York, United States.
Neuroscience Institute, NYU Langone Health, NYU Grossman School of Medicine, New York, New York, United States.
Department of Electrical and Computer Engineering, New York University Tandon School of Engineering, Brooklyn, New York, United States.
Center for Neural Science, NYU College of Arts and Sciences, New York, New York, United States.
Department of Physiology and Neuroscience, NYU Langone Health, NYU Grossman School of Medicine, New York, New York, United States.

Ronald Zambrano (R)

Department of Ophthalmology, NYU Langone Health, NYU Grossman School of Medicine, New York, New York, United States.

Mengfei Wu (M)

Department of Ophthalmology, NYU Langone Health, NYU Grossman School of Medicine, New York, New York, United States.

Mengling Liu (M)

Department of Ophthalmology, NYU Langone Health, NYU Grossman School of Medicine, New York, New York, United States.

Behnam Tayebi (B)

Department of Ophthalmology, NYU Langone Health, NYU Grossman School of Medicine, New York, New York, United States.
Neuroscience Institute, NYU Langone Health, NYU Grossman School of Medicine, New York, New York, United States.

Yuanbo Wang (Y)

Opticent Inc., Evanston, Illinois, United States.

Ian Rubinoff (I)

Department of Biomedical Engineering, Northwestern University, Evanston, Illinois, United States.

Xiaorong Liu (X)

Department of Biology, University of Virginia, Charlottesville, Virginia, United States.

Gadi Wollstein (G)

Department of Ophthalmology, NYU Langone Health, NYU Grossman School of Medicine, New York, New York, United States.
Department of Biomedical Engineering, New York University Tandon School of Engineering, Brooklyn, New York, United States.

Hao F Zhang (HF)

Department of Biomedical Engineering, Northwestern University, Evanston, Illinois, United States.

Hiroshi Ishikawa (H)

Department of Ophthalmology, NYU Langone Health, NYU Grossman School of Medicine, New York, New York, United States.
Department of Biomedical Engineering, New York University Tandon School of Engineering, Brooklyn, New York, United States.
Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Oregon, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH